Els Beirnaert

Formatted anti–tumor necrosis factor α VHH proteins derived from camelids show superior potency and targeting to inflamed joints in a murine model of collagen‐induced arthritis

Ken Coppieters, Torsten Dreier, Karen Silence et al. · Arthritis & Rheumatism · 2006 · 301 citations

Medicine, Immunology, Molecular Biology +17

Orally administered L. lactis secreting an anti-TNF Nanobody demonstrate efficacy in chronic colitis

Klaas Vandenbroucke, Hans de Haard, Els Beirnaert et al. · Mucosal Immunology · 2009 · 284 citations · Full text

Life Sciences, Clinical Sciences, Immunology +14

The preclinical pharmacology of the high affinity anti-IL-6R Nanobody® ALX-0061 supports its clinical development in rheumatoid arthritis

Maarten Van Roy, Cedric Ververken, Els Beirnaert et al. · Arthritis Research & Therapy · 2015 · 179 citations · Full text

Medicine, Immunology, Pharmacology +14

Llama Antibody Fragments with Cross-Subtype Human Immunodeficiency Virus Type 1 (HIV-1)-Neutralizing Properties and High Affinity for HIV-1 gp120

Anna Forsman, Els Beirnaert, Marlén M. I. Aasa-Chapman et al. · Journal of Virology · 2008 · 123 citations · Full text

Life Sciences, Immunology, Infectious Diseases +17

Bivalent Llama Single-Domain Antibody Fragments against Tumor Necrosis Factor Have Picomolar Potencies due to Intramolecular Interactions

Els Beirnaert, Aline Desmyter, Silvia Spinelli et al. · Frontiers in Immunology · 2017 · 87 citations · Full text

Pharmacy, Immunology, Pharmacology +17